SGO1 and nonpapillary renal cell carcinoma: All the data above indicated that SGOL1 overexpression was associated with adverse clinicopathological characteristics and may impact tumor initiation and progression, which indicated that SGOL1 could be a diagnostic biomarker for ccRCC.